• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 04 Nov 2025

We Project 1Q:F26 EPS Grew 5% On Flat Revenue; Look For Hardware Demand To Improve And Hybrid Investments To Start Yielding Positive Results In F2026; Maintain $66 Price Target


SCANSOURCE (SCSC:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Gregory Burns

    • 10 pages


 

We estimate revenue in 1Q:F26 increased 0.2% year over year to $776.7 million and EPS grew 4.8% to $0.88. We think hardware demand is improving, and we look for the investments ScanSource is making to drive significant recurring revenue and margin growth over the next three years. We think the company's improving cash generation is being overlooked. ScanSource generated $104 million, or $4.37 per share, of free cash flow in F2025. Management now projects the company will maintain a cash conversion rate of 80% of net income. ScanSource ended F2025 with $126 million of cash and debt of just $136 million. We maintain our $66 price target based on 14x our F2027 EPS estimate of $4.74. Our moderate risk rating credits ScanSource's profit history and modest leverage.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

We Project 1Q:F26 EPS Grew 5% On Flat Revenue; Look For Hardware Demand To Improve And Hybrid Investments To Start Yielding Positive Results In F2026; Maintain $66 Price Target


SCANSOURCE (SCSC:NYSE) | 0 0 0.0%


  • Published: 04 Nov 2025
  • Author: Gregory Burns
  • Pages: 10
  • Sidoti & Company


We estimate revenue in 1Q:F26 increased 0.2% year over year to $776.7 million and EPS grew 4.8% to $0.88. We think hardware demand is improving, and we look for the investments ScanSource is making to drive significant recurring revenue and margin growth over the next three years. We think the company's improving cash generation is being overlooked. ScanSource generated $104 million, or $4.37 per share, of free cash flow in F2025. Management now projects the company will maintain a cash conversion rate of 80% of net income. ScanSource ended F2025 with $126 million of cash and debt of just $136 million. We maintain our $66 price target based on 14x our F2027 EPS estimate of $4.74. Our moderate risk rating credits ScanSource's profit history and modest leverage.

More Content

More Content

2Q:F26 Revenue, EPS Missed Our Forecasts On Timing Of Large Orders; Lower Earnings Estimates, But Still Expect SCSC To Generate Strong Cash Flow; Lower Target To $62 (From $66)

Companies: SCANSOURCE

Sidoti & Company

Leading indicators for OECD industrial production

Companies: SHOT MLHYE NSKOG SBS CMOTECB HYEG SDOS BILL ESSITYA HYHY HYDI SCSC SCST SANNAB RROS SES SCOL HCD SSO HYDROGEN SCATC MLSHD HYGN NCHI H HYG SCY SCST HEART STG SDOS HYW SPEAS STG SCAPE SBOK BRGB ELK HOLMB BRG SCSC BRG HUH1V STERV UPM SCANFL MLHYE MATA HYDP HYD SCLP MTNGH 2079610D SHOT SCANA HYPRO NSKOG SCAS HUIN SCAN SPGR ESSITYB HOLMB SMSMED 3974 4845 101670 NRGB HYFM HUI SCW SCOD ALHRS HML BILL SIG Y73 NGRM SCL SBOK CMOTECB HYEG HYDRO SCN HG 6195 HYHY HYGN HYDI PYBX SDNI ELK RROS DRL HGEN HDF HPT SES ELO 7820

ABG Sundal Collier

We Project 2Q:F26 EPS Grew 26.5% On 8% Revenue Growth, As Hardware Demand In The Technology Segments SCSC Serves Has Picked Up In Recent Quarters; Maintain $66 Target

Companies: SCANSOURCE

Sidoti & Company

Q3 preview

Companies: SHOT SBS CMOTECB SDOS SCSC SCST SANNAB SES SCOL SSO SCATC MLSHD NCHI SCY SCST HEART STG SDOS SPEAS STG SCAPE SBOK SCSC SCANFL MATA SCLP MTNGH 2079610D SHOT SCANA SCAS SCAN SPGR SMSMED 3974 4845 SCW SCOD SIG Y73 SCL SBOK CMOTECB SCN 6195 SDNI SES 7820

ABG Sundal Collier

1Q:F26 Revenue Missed, But Improving Profitability Of Specialty Technology Segment Drove Better-Than-Projected EPS; Maintain $66 Price Target

Companies: SCANSOURCE

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • ISTAR Capital
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • ISTAR Capital
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In